Market Dynamics of CNS Disorder Gene Therapies

The Global Gene Therapy in CNS Disorder Industry is poised for an unprecedented surge, with projections indicating a remarkable growth trajectory. According to industry forecasts, the market is expected to achieve a value of US$ 8.2 billion in 2023, catapulting to an astounding US$ 113.04 billion by 2033. This remarkable ascent is underpinned by a compound annual growth rate (CAGR) of 30% anticipated between 2023 and 2033, following a robust CAGR of 19% during the period from 2018 to 2022.